1. Home
  2. WW vs CLSD Comparison

WW vs CLSD Comparison

Compare WW & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WW
  • CLSD
  • Stock Information
  • Founded
  • WW 1961
  • CLSD 2011
  • Country
  • WW United States
  • CLSD United States
  • Employees
  • WW N/A
  • CLSD N/A
  • Industry
  • WW Other Consumer Services
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • WW Consumer Discretionary
  • CLSD Health Care
  • Exchange
  • WW Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • WW 75.9M
  • CLSD 70.5M
  • IPO Year
  • WW 2001
  • CLSD 2016
  • Fundamental
  • Price
  • WW $0.92
  • CLSD $0.97
  • Analyst Decision
  • WW Buy
  • CLSD Strong Buy
  • Analyst Count
  • WW 5
  • CLSD 6
  • Target Price
  • WW $3.44
  • CLSD $5.33
  • AVG Volume (30 Days)
  • WW 2.8M
  • CLSD 144.0K
  • Earning Date
  • WW 02-26-2025
  • CLSD 03-11-2025
  • Dividend Yield
  • WW N/A
  • CLSD N/A
  • EPS Growth
  • WW N/A
  • CLSD N/A
  • EPS
  • WW N/A
  • CLSD N/A
  • Revenue
  • WW $807,465,000.00
  • CLSD $7,703,000.00
  • Revenue This Year
  • WW N/A
  • CLSD N/A
  • Revenue Next Year
  • WW N/A
  • CLSD $91.87
  • P/E Ratio
  • WW N/A
  • CLSD N/A
  • Revenue Growth
  • WW N/A
  • CLSD 248.39
  • 52 Week Low
  • WW $0.67
  • CLSD $0.80
  • 52 Week High
  • WW $5.22
  • CLSD $2.12
  • Technical
  • Relative Strength Index (RSI)
  • WW 39.73
  • CLSD 47.63
  • Support Level
  • WW $1.03
  • CLSD $0.90
  • Resistance Level
  • WW $1.19
  • CLSD $0.96
  • Average True Range (ATR)
  • WW 0.09
  • CLSD 0.05
  • MACD
  • WW -0.02
  • CLSD 0.00
  • Stochastic Oscillator
  • WW 2.94
  • CLSD 50.63

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: